Ex vivo evaluation of tumor cell specific drug responses in malignant pleural effusions.

about

Ex vivo evaluation of tumor cell specific drug responses in malignant pleural effusions.

Item

http://www.wikidata.org/entity/Q47127588

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Ex vivo evaluation of tumor cell specific drug responses in malignant pleural effusions.

@en

Ex vivo evaluation of tumor cell specific drug responses in malignant pleural effusions.

@nl

type

Item

label

Ex vivo evaluation of tumor cell specific drug responses in malignant pleural effusions.

@en

Ex vivo evaluation of tumor cell specific drug responses in malignant pleural effusions.

@nl

prefLabel

Ex vivo evaluation of tumor cell specific drug responses in malignant pleural effusions.

@en

Ex vivo evaluation of tumor cell specific drug responses in malignant pleural effusions.

@nl

P1476

Ex vivo evaluation of tumor cell specific drug responses in malignant pleural effusions.

@en

P2093

Anders Hjerpe

http://www.w3.org/2001/XMLSchema#string

Carl-Olof Hillerdal

http://www.w3.org/2001/XMLSchema#string

Gunnar Hillerdal

http://www.w3.org/2001/XMLSchema#string

Katalin Dobra

http://www.w3.org/2001/XMLSchema#string

Rita Ötvös

http://www.w3.org/2001/XMLSchema#string

Sulaf Abd Own

http://www.w3.org/2001/XMLSchema#string

Åsa-Lena Dackland

http://www.w3.org/2001/XMLSchema#string

P2860

Prediction of Cancer Drug Resistance and Implications for Personalized Medicine

A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V

Variation in drug sensitivity of malignant mesothelioma cell lines with substantial effects of selenite and bortezomib, highlights need for individualized therapy

The third dimension bridges the gap between cell culture and live tissue

Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer

Spheroid-based drug screen: considerations and practical approach

Chronology of cellular alterations during 7-ketocholesterol-induced cell death on A7R5 rat smooth muscle cells: analysis by time lapse-video microscopy and conventional fluorescence microscopy.

Phase III study by the Norwegian lung cancer study group: pemetrexed plus carboplatin compared with gemcitabine plus carboplatin as first-line chemotherapy in advanced non-small-cell lung cancer.

A randomized phase II trial of gemcitabine plus carboplatin: biweekly versus standard schedules in patients with advanced non-small cell lung cancer.

Apoptosis, cell adhesion and the extracellular matrix in the three-dimensional growth of multicellular tumor spheroids.

P304

82885-82896

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.20889

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Tünde Szatmári

P577

2017-09-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29137310

http://www.w3.org/2001/XMLSchema#string

P932

5669936

http://www.w3.org/2001/XMLSchema#string